
Monday, June 27, 2022 2:00:19 PM
NIH funded trial for severe AD..
Wonder what happens when you bring an AD patient back from the abyss?
Do they remember yesterdays or just tomorrows?
Prayers it’s both

Liked By
Spread the love. Be the first to like this post!
Recent ANVS News
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 02/08/2023 10:12:56 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 01/20/2023 10:44:43 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 01/20/2023 10:43:38 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 01/20/2023 10:41:48 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 01/20/2023 10:41:47 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 01/20/2023 10:40:33 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 01/06/2023 09:06:37 PM
- Annovis Bio Announces New Appointments to Strengthen Its Senior Leadership Team • PR Newswire (US) • 01/06/2023 12:30:00 PM
- Annovis Bio Announces Third Quarter 2022 Results and Provides Corporate Update • PR Newswire (US) • 11/08/2022 10:35:00 PM
- Quarterly Report (10-q) • Edgar (US Regulatory) • 11/08/2022 09:45:41 PM
- Annovis Bio to Present at the 2022 ThinkEquity Investor Conference • PR Newswire (US) • 10/20/2022 11:30:00 AM
- Annovis Bio Announces Publication of Phase 2a Clinical Data in The Journal of Prevention of Alzheimer's Disease • PR Newswire (US) • 10/11/2022 11:30:00 AM
- H.C. Wainwright Sticks to Its Buy Rating for Annovis Bio (ANVS) • TipRanks • 10/11/2022 08:46:40 AM
- Annovis Bio Shares Rise 6% After FDA Approves Buntanetap Study • Dow Jones News • 10/06/2022 02:34:00 PM
- Annovis Bio Announces FDA Authorization to Proceed with Phase 2/3 Trial for Buntanetap in Alzheimer's Disease • PR Newswire (US) • 10/06/2022 11:30:00 AM
- Annovis Bio to Present at the 2022 Ladenburg Thalmann Healthcare Conference • PR Newswire (US) • 09/29/2022 11:30:00 AM
- Annovis Bio Announces Publication of Patents Covering the Treatment of Amyloid Lateral Sclerosis, Huntington's Disease and Prion Diseases • PR Newswire (US) • 09/13/2022 11:30:00 AM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 09/12/2022 09:10:14 PM
- Annovis Bio's CEO Maria Maccecchini Issues Letter to Stockholders • PR Newswire (US) • 09/08/2022 11:30:00 AM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 08/30/2022 10:05:03 AM
- Annovis Bio Appoints Henry Hagopian III as Chief Financial Officer • PR Newswire (US) • 08/29/2022 08:00:00 PM
- Annovis Bio (ANVS) Gets a Buy from Maxim Group • TipRanks • 08/25/2022 01:45:21 PM
- Annovis Bio Announces First Patient Dosed in Phase 3 Trial in Patients with Early Parkinson's Disease • PR Newswire (US) • 08/24/2022 11:30:00 AM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 08/08/2022 12:31:32 PM
- Annovis Bio Announces Second Quarter 2022 Results and Provides Corporate Update • PR Newswire (US) • 08/08/2022 11:30:00 AM
Hollywall Entertainment Inc., (OTC:HWAL) Announces the completion of its 2021 and 2020 Audit (s) • HWAL • Mar 24, 2023 12:48 PM
Glucose Health, Inc. Fiscal 2022 Annual Report • GLUC • Mar 23, 2023 3:23 PM
Nextech3D.ai Announces Its AI-Powered SaaS Platform Toggle3D Experiences A +963% Jump in Users in 60-Days Crossing Over 1000 Users • NTAR • Mar 23, 2023 7:07 AM
Lifecycle Assessment by Benchmark Shows TMC's NORI-D Nodule Project Could Outperform Land-Based Routes of Producing Nickel, Copper and Cobalt in Almost Every Impact Category Analyzed • TMC • Mar 22, 2023 1:44 PM
Fineqia Announces Partnership with Paris Blockchain Week to Accelerate Digital Asset Innovation • FNQQF • Mar 22, 2023 10:03 AM
E-Cite and ClearMarket Launch Nationwide EV Distribution Network Becoming the First All EV Dealership Opening in the Cerritos Auto Square, the World's Largest Automall • VAPR • Mar 22, 2023 9:41 AM